Sibylle Loibl

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 39

Top Topics

Early Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Carmine Valenza, Dario Trapani, Sibylle Loibl, Stephen K L Chia, Harold J Burstein, Curigliano Giuseppe
Optimizing Postneoadjuvant Treatment in Patients With Early Breast Cancer Achieving Pathologic Complete Response. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Paul Jank, Thomas Karn, Marion T van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut Engels, Christine Solbach, Kurt Diebold, Frederic Marmé, Volkmar Mueller, Andreas Schneeweiß, Hans-Peter Sinn, Tanja Fehm, Christian Schem, Elmar Stickeler, Peter Andreas Fasching, Jan Budczies, Bärbel Felder, Valentina Nekljudova, Johannes Holtschmidt, Michael Untch, Carsten Denkert, Sibylle Loibl
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric P Winer, Jonas Bergh, Richard D Gelber, Eleonora Restuccia, Young-Hyuck Im, Chiun-Sheng Huang, Florence Dalenc, Isabel Calvo, Marion Procter, Carmela Caballero, Emma Clark, Alice Raimbault, Robin McConnell, Estefania Monturus, Evandro de Azambuja, Henry Leonidas Gómez, Judith M Bliss, Giuseppe Viale, Jose Bines, Martine J Piccart, null null
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Alexios Matikas, Volker Möbus, Richard Greil, Anne Andersson, Günther G Steger, Michael Untch, Tommy Fornander, Per Malmström, Sabine Schmatloch, Hemming Johansson, Mats Hellström, Yvonne Brandberg, Michael Gnant, Sibylle Loibl, Theodoros Foukakis, Jonas Bergh, null null
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Aditya Bardia, Hope S Rugo, Sara M Tolaney, Delphine Loirat, Kevin Punie, Mafalda Oliveira, Adam M Brufsky, Kevin M Kalinsky, Javier Cortes, Joyce O' Shaughnessy, Véronique Diéras, Lisa Anne Carey, Luca Gianni, Martine J Piccart, Sibylle Loibl, Oh Kyu Yoon, Yang Pan, Scott Hofsess, See-Chun Phan, Sara Alsterlind Hurvitz
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, Andreas Schneeweiss, Eva-Maria Grischke, Grischa Wachsmann, Helmut Forstbauer, Michael Untch, Frederik Marmé, Jens-Uwe Blohmer, Christian Jackisch, Jens Huober, Elmar Stickeler, Mattea Reinisch, Theresa Link, Bruno Valentin Sinn, Wolfgang Janni, Carsten Denkert, Sabine Seiler, Christine Solbach, Sabine Schmatloch, Julia Rey, Sibylle Loibl
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer. NPJ breast cancer 10 (1) (2024)
Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, Andreas Schneeweiss, Eva-Maria Grischke, Grischa Wachsmann, Helmut Forstbauer, Michael Untch, Frederik Marmé, Jens-Uwe Blohmer, Christian Jackisch, Jens Huober, Elmar Stickeler, Mattea Reinisch, Theresa Link, Bruno Valentin Sinn, Wolfgang Janni, Carsten Denkert, Sabine Seiler, Christine Solbach, Sabine Schmatloch, Julia Rey, Sibylle Loibl
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer. NPJ breast cancer 10 (1) (2024)
Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, Andreas Schneeweiss, Eva-Maria Grischke, Grischa Wachsmann, Helmut Forstbauer, Michael Untch, Frederik Marmé, Jens-Uwe Blohmer, Christian Jackisch, Jens Huober, Elmar Stickeler, Mattea Reinisch, Theresa Link, Bruno Valentin Sinn, Wolfgang Janni, Carsten Denkert, Sabine Seiler, Christine Solbach, Sabine Schmatloch, Julia Rey, Sibylle Loibl
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer. NPJ breast cancer 10 (1) (2024)
Ian E Krop, Lorenza Mittempergher, Joseph N Paulson, Fabrice Andre, Hervé R Bonnefoi, Sherene Loi, Sibylle Loibl, Richard D Gelber, Carmela Caballero, Rajith Bhaskaran, Christa Dreezen, Andrea R Menicucci, René Bernards, Laura J van 't Veer, Martine J Piccart
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial. JCO precision oncology 8 (2024)
Carmine Valenza, Dario Trapani, Sibylle Loibl, Stephen K L Chia, Harold J Burstein, Curigliano Giuseppe
Optimizing Postneoadjuvant Treatment in Patients With Early Breast Cancer Achieving Pathologic Complete Response. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Paul Jank, Thomas Karn, Marion T van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut Engels, Christine Solbach, Kurt Diebold, Frederic Marmé, Volkmar Mueller, Andreas Schneeweiß, Hans-Peter Sinn, Tanja Fehm, Christian Schem, Elmar Stickeler, Peter Andreas Fasching, Jan Budczies, Bärbel Felder, Valentina Nekljudova, Johannes Holtschmidt, Michael Untch, Carsten Denkert, Sibylle Loibl
An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in breast cancer patients from four prospective clinical trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc E Buyse, Charles E Geyer, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Pierre Squifflet, Everardo Delforge Saad, Dominik Heinzmann, Carsten Denkert, Priya Rastogi, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peter Andreas Fasching, Christopher W Szeto, Carsten Denkert, Stephen Charles Benz, Karsten E Weber, Patricia Spilman, Jan Budczies, Andreas Schneeweiß, Elmar Stickeler, Sabine Schmatloch, Christian Jackisch, Thomas Karn, Hans-Peter Sinn, Mathias Warm, Marion T van Mackelenbergh, Shahrooz Rabizadeh, Christian Schem, Ernst Heinmöller, Volkmar Mueller, Frederic Marmé, Patrick Soon-Shiong, Valentina Nekljudova, Michael Untch, Sibylle Loibl
Inferred immune-cell activity is an independent predictor of HER2 negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Terence M Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten E Weber, Peter Andreas Fasching, Carsten Denkert, Jenny Furlanetto, Ernst Heinmöller, Sabine Schmatloch, Thomas Karn, Christopher W Szeto, Marion T van Mackelenbergh, Valentina Nekljudova, Elmar Stickeler, Patrick Soon-Shiong, Christian Schem, Thomas Mairinger, Volkmar Mueller, Frederic Marmé, Michael Untch, Sibylle Loibl
Caveolin gene expression predicts clinical outcomes for early-stage HER2-negative breast cancer treated with paclitaxel-based chemotherapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Theresa Link, Jens-Uwe Blohmer, Wolfgang Daniel Schmitt, Jan Dominik Kuhlmann, Marianne Just, Michael Untch, Oliver Stotzer, Peter Andreas Fasching, Marc Thill, Mattea Reinisch, Andreas Schneeweiß, Pauline Wimberger, Sabine Seiler, Jens Huober, Christian Jackisch, Kerstin Rhiem, Claus Hanusch, Bruno Valentin Sinn, Valentina Nekljudova, Sibylle Loibl, Carsten Denkert
RANK expression as an independent predictor for response to neoadjuvant chemotherapy in luminal-like breast cancer - a translational insight from the GeparX trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Carsten Denkert, Chiara Lambertini, Peter Andreas Fasching, Katherine L Pogue-Geile, Max Senna Mano, Michael Untch, Norman Wolmark, Chiun-Sheng Huang, Sibylle Loibl, Eleftherios P P Mamounas, Charles E Geyer, Peter C Lucas, Thomas Boulet, Chunyan Song, Gail D Lewis Phillips, Malgorzata Nowicka, Sanne de Haas, Mark Basik
Biomarker Data From the Phase III KATHERINE Study of Adjuvant T-DM1 Versus Trastuzumab for Residual Invasive Disease After Neoadjuvant Therapy for HER2-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jens Huober, Marion T van Mackelenbergh, Andreas Schneeweiss, Fenja Seither, Jens-Uwe Blohmer, Carsten Denkert, Hans Tesch, Claus Hanusch, Christoph Salat, Kerstin Rhiem, Christine Solbach, Peter Andreas Fasching, Christian Jackisch, Mattea Reinisch, Bianca Lederer, Keyur Mehta, Theresa Link, Valentina Nekljudova, Sibylle Loibl, Michael Untch
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy. NPJ breast cancer 9 (1) (2023)
Pierre Squifflet, Everardo Delforge Saad, Sibylle Loibl, Marion T van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Dominik Heinzmann, Carsten Denkert, Charles E Geyer, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, Marc E Buyse, null null
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Pfeiler Georg, Dominik Hlauschek, Erica L Mayer, Christine Deutschmann, Stephanie Kacerovsky-Strobl, Miguel Martin, Jane Lowe Meisel, Nicholas Zdenkowski, Sibylle Loibl, Marija Balić, Haeseong Park, Aleix Prat, Claudine Isaacs, Emilio Bajetta, Justin M Balko, Merixtell Bellet-Ezquerra, Judith M Bliss, Harold J Burstein, Fatima Cardoso, Hannes Fohler, Theodoros Foukakis, Karen A Gelmon, Matthew P Goetz, Tufia C Haddad, Hiroji Iwata, Jacek Jassem, Soo-Chin Lee, Barbro Linderholm, Maartje Los, Eleftherios P P Mamounas, Kathy D Miller, Patrick G Morris, Elisabetta Munzone, Einav Nili Gal-Yam, Alistair Ring, Lois E Shepherd, Christian F Singer, Christoph Thomssen, Ling Ming Tseng, Pinuccia Valagussa, Eric P Winer, Antonio C Wolff, Francesco Ravera, Jana Machacek-Link, Céline Schurmans, Xin Huang, Eric Gauthier, Christian Fesl, Amylou C Dueck, Angela M DeMichele, Michael Gnant, null null
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hanne Lefrère, Kat S Moore, Giuseppe Floris, Joyce Sanders, Iris M Seignette, Tycho Bismeijer, Dennis Peters, Annegien Broeks, Erik Hooijberg, Kristel Van Calsteren, Patrick Neven, Ellen Warner, Fedro Alessandro Peccatori, Sibylle Loibl, Charlotte Maggen, Sileny N Han, Katarzyna Joanna Jerzak, Daniela Annibali, Diether Lambrechts, Karin E de Visser, Lodewyk F A Wessels, Liesbeth Lenaerts, Frédéric Amant
Poor outcome in postpartum breast cancer patients is associated with distinct molecular and immunological features. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Prudence A Francis, Gini F Fleming, István Láng, Eva Ciruelos Gil, Hervé R Bonnefoi, Meritxell Bellet-Ezquerra, Antonio Bernardo, Miguel A Climent, Silvana Martino, Begoña Bermejo, Harold J Burstein, Nancy E Davidson, Charles E Geyer, Barbara A Walley, James N Ingle, Robert E Coleman, Bettina Müller, Fanny Le Du, Sibylle Loibl, Eric P Winer, Barbara Ruepp, Sherene Loi, Marco Colleoni, Alan S Coates, Richard D Gelber, Aron Goldhirsch, Meredith M Regan, null null
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (7) (2022)
Sibylle Loibl, Chiun-Sheng Huang, Max S Mano, Eleftherios P Mamounas, Charles E Geyer, Michael Untch, Jean-Christophe Thery, Ingo Schwaner, Steven Limentani, Niklas Loman, Kristina Lübbe, Jenny C Chang, Thomas Hatschek, David Tesarowski, Chunyan Song, Sanne Lysbet de Haas, Thomas Boulet, Chiara Lambertini, Norman Wolmark
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE. NPJ breast cancer 8 (1) (2022)
Kim R M Blenman, Michał Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y Ibrahim, Tristen Park, Andrea L M Silber, Denise M Wolf, Emily Reisenbichler, Carsten Denkert, Bruno Valentin Sinn, Mariya Rozenblit, Julia Foldi, David L Rimm, Sibylle Loibl, Lajos Pusztai
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Prudence A Francis, Gini F Fleming, István Láng, Eva Ciruelos Gil, Hervé R Bonnefoi, Meritxell Bellet-Ezquerra, Antonio Bernardo, Miguel A Climent, Silvana Martino, Begoña Bermejo, Harold J Burstein, Nancy E Davidson, Charles E Geyer, Barbara A Walley, James N Ingle, Robert E Coleman, Bettina Müller, Fanny Le Du, Sibylle Loibl, Eric P Winer, Barbara Ruepp, Sherene Loi, Marco Colleoni, Alan S Coates, Richard D Gelber, Aron Goldhirsch, Meredith M Regan, null null
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Prudence A Francis, Gini F Fleming, István Láng, Eva Ciruelos Gil, Hervé R Bonnefoi, Meritxell Bellet-Ezquerra, Antonio Bernardo, Miguel A Climent, Silvana Martino, Begoña Bermejo, Harold J Burstein, Nancy E Davidson, Charles E Geyer, Barbara A Walley, James N Ingle, Robert E Coleman, Bettina Müller, Fanny Le Du, Sibylle Loibl, Eric P Winer, Barbara Ruepp, Sherene Loi, Marco Colleoni, Alan S Coates, Richard D Gelber, Aron Goldhirsch, Meredith M Regan, null null
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Massimo Cristofanilli, Hope S Rugo, Seock-Ah Im, Dennis J Slamon, Nadia Harbeck, Igor Bondarenko, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Hiroji Iwata, Ben O'Leary, Fabrice Andre, Sibylle Loibl, Eustratios Bananis, Yuan Liu, Xin Huang, Sindy Kim, Maria Jose Lechuga Frean, Nicholas C Turner
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Prudence A Francis, Gini F Fleming, István Láng, Eva Ciruelos Gil, Hervé R Bonnefoi, Meritxell Bellet-Ezquerra, Antonio Bernardo, Miguel A Climent, Silvana Martino, Begoña Bermejo, Harold J Burstein, Nancy E Davidson, Charles E Geyer, Barbara A Walley, James N Ingle, Robert E Coleman, Bettina Müller, Fanny Le Du, Sibylle Loibl, Eric P Winer, Barbara Ruepp, Sherene Loi, Marco Colleoni, Alan S Coates, Richard D Gelber, Aron Goldhirsch, Meredith M Regan, null null
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Prudence A Francis, Gini F Fleming, István Láng, Eva Ciruelos Gil, Hervé R Bonnefoi, Meritxell Bellet-Ezquerra, Antonio Bernardo, Miguel A Climent, Silvana Martino, Begoña Bermejo, Harold J Burstein, Nancy E Davidson, Charles E Geyer, Barbara A Walley, James N Ingle, Robert E Coleman, Bettina Müller, Fanny Le Du, Sibylle Loibl, Eric P Winer, Barbara Ruepp, Sherene Loi, Marco Colleoni, Alan S Coates, Richard D Gelber, Aron Goldhirsch, Meredith M Regan, null null
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (7) (2022)
Prudence A Francis, Gini F Fleming, István Láng, Eva Ciruelos Gil, Hervé R Bonnefoi, Meritxell Bellet-Ezquerra, Antonio Bernardo, Miguel A Climent, Silvana Martino, Begoña Bermejo, Harold J Burstein, Nancy E Davidson, Charles E Geyer, Barbara A Walley, James N Ingle, Robert E Coleman, Bettina Müller, Fanny Le Du, Sibylle Loibl, Eric P Winer, Barbara Ruepp, Sherene Loi, Marco Colleoni, Alan S Coates, Richard D Gelber, Aron Goldhirsch, Meredith M Regan, null null
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (7) (2022)
Karolina Edlund, Katrin Madjar, Antje Lebrecht, Bahriye Aktaş, Henryk Pilch, Gerald Hoffmann, Manfred Hofmann, Hans-Christian Kolberg, Daniel Boehm, Marco Battista, Martina Seehase, Kathrin Stewen, Susanne Gebhard, Cristina Cadenas, Rosemarie Marchan, Walburgis Brenner, Annette Hasenburg, Heinz Koelbl, Christine Solbach, Mathias Gehrmann, Berno Tanner, Karsten E Weber, Sibylle Loibl, Agapios Sachinidis, Jörg Rahnenführer, Marcus Schmidt, Jan G Hengstler
Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (8) (2021)
Sibylle Loibl, Frederic Marmé, Miguel Martin, Michael Untch, Hervé R Bonnefoi, Sung-Bae Kim, Harry Bear, Nicole McCarthy, Mireia Melé Olivé, Karen Gelmon, José García-Sáenz, Catherine M Kelly, Toralf Reimer, Masakazu Toi, Hope S Rugo, Carsten Denkert, Michael Gnant, Andreas Makris, Maria Koehler, Cynthia Huang-Bartelett, Maria Jose Lechuga Frean, Marco Colleoni, Gustavo Werutsky, Sabine Seiler, Nicole Burchardi, Valentina Nekljudova, Gunter von Minckwitz
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Bruno Valentin Sinn, Sibylle Loibl, Claus A Hanusch, Dirk-Michael Zahm, Hans-Peter Sinn, Michael Untch, Karsten Weber, Thomas Karn, Clemens Becker, Frederic Marmé, Wolfgang Daniel Schmitt, Volkmar Müller, Christian Schem, Denise Treue, Elmar Stickeler, Frederik Klauschen, Nicole Burchardi, Jenny Furlanetto, Marion van Mackelenbergh, Peter Andreas Fasching, Andreas Schneeweiß, Carsten Denkert
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Sibylle Loibl, Valentina Nekljudova, Carsten Denkert
Reply to Y. Kawamura et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Eva Maria Ciruelos, Hope S Rugo, Ingrid A Mayer, Christelle Levy, Frédéric Forget, Juan Ignacio Delgado Mingorance, Tamar Safra, Norikazu Masuda, Yeon Hee Park, Dejan Juric, PierFranco Conte, Mario Campone, Sibylle Loibl, Hiroji Iwata, Xiaolei Zhou, Jinhee Park, Antonia Ridolfi, Ines Lorenzo, Fabrice Andre
Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Larissa A Korde, Mark R Somerfield, Lisa Anne Carey, Jennie R Crews, Neelima Denduluri, E Shelley Hwang, Seema Ahsan Khan, Sibylle Loibl, Elizabeth A Morris, Alejandra Perez, Meredith M Regan, Patricia A Spears, Preeti K Sudheendra, William Fraser Symmans, Rachel L Yung, Brittany E Harvey, Dawn L Hershman
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)